Authors: Redman, AM Johnson, JS Dally, R Swartz, S Wild, H Paulsen, H Caringal, Y Gunn, D Renick, J Osterhout, M Kingery-Wood, J Smith, RA Lee, W Dumas, J Wilhelm, SM Housley, TJ Bhargava, A Ranges, GE Shrikhande, A Young, D Bombara, M Scott, WJ

Citation: Am. Redman et al., p38 Kinase inhibitors for the treatment of arthritis and osteoporosis: Thienyl, furyl, and pyrrolyl ureas, BIOORG MED, 11(1), 2001, pp. 9-12

Authors: Dumas, J Sibley, R Riedl, B Monahan, MK Lee, W Lowinger, TB Redman, AM Johnson, JS Kingery-Wood, J Scott, WJ Smith, RA Bobko, M Schoenleber, R Ranges, GE Housley, TJ Bhargava, A Wilhelm, SM Shrikhande, A

Citation: J. Dumas et al., Discovery of a new class of p38 kinase inhibitors, BIOORG MED, 10(18), 2000, pp. 2047-2050

Authors: Dumas, J Hatoum-Mokdad, H Sibley, R Riedl, B Scott, WJ Monahan, MK Lowinger, TB Brennan, C Natero, R Turner, T Johnson, JS Schoenleber, R Bhargava, A Wilhelm, SM Housley, TJ Ranges, GE Shrikhande, A

Citation: J. Dumas et al., 1-Phenyl-5-pyrazolyl ureas: Potent and selective p38 kinase inhibitors, BIOORG MED, 10(18), 2000, pp. 2051-2054